Total Long Term Debt (Quarterly) Chart

View Total Long Term Debt (Quarterly) for CDNA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Long Term Debt (Quarterly) Chart
Start Trial

Historical Total Long Term Debt (Quarterly) Data

View and export this data back to 2013. Start Trial.
Date Value
June 30, 2026 13.20M
March 31, 2026 17.84M
December 31, 2025 19.68M
September 30, 2025 21.21M
June 30, 2025 22.78M
March 31, 2025 24.07M
December 31, 2024 22.26M
September 30, 2024 23.84M
June 30, 2024 25.39M
March 31, 2024 26.89M
December 31, 2023 28.28M
September 30, 2023 29.25M
June 30, 2023 30.59M
March 31, 2023 32.01M
December 31, 2022 33.41M
September 30, 2022 34.71M
June 30, 2022 16.06M
March 31, 2022 16.73M
December 31, 2021 17.39M
September 30, 2021 17.88M
June 30, 2021 17.79M
March 31, 2021 18.50M
December 31, 2020 16.14M
September 30, 2020 16.66M
June 30, 2020 17.20M
Date Value
March 31, 2020 17.73M
December 31, 2019 0.28M
September 30, 2019 0.332M
June 30, 2019 0.385M
March 31, 2019 0.405M
December 31, 2018 0.421M
September 30, 2018 13.88M
June 30, 2018 13.79M
March 31, 2018 10.43M
December 31, 2017 34.07M
September 30, 2017 36.22M
June 30, 2017 33.94M
March 31, 2017 32.45M
December 31, 2016 24.01M
September 30, 2016 26.57M
June 30, 2016 28.26M
March 31, 2016 15.85M
December 31, 2015 15.82M
September 30, 2015 15.80M
June 30, 2015 15.83M
March 31, 2015 15.73M
December 31, 2014 11.48M
September 30, 2014 12.81M
June 30, 2014 18.97M
March 31, 2014 15.11M

Total Long Term Debt Definition

Represents a company's total debt maturing for more than 12 months of the reporting period.

Read full definition.

Total Long Term Debt (Quarterly) Range, Past 5 Years

View Total Long Term Debt (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Long Term Debt (Quarterly) Benchmarks

View Total Long Term Debt (Quarterly) Benchmarks
Start Trial
Natera, Inc. 143.07M
Caris Life Sciences, Inc. 446.04M
Myriad Genetics, Inc. 203.20M
BioRestorative Therapies, Inc. 0.00
Exagen, Inc. 26.68M